SciELO - Scientific Electronic Library Online

 
vol.131 número5Espondilodiscitis: Análisis de una serie de 25 casosEnfermedad de Paget en Chile: una serie de 15 pacientes índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

Compartir


Revista médica de Chile

versión impresa ISSN 0034-9887

Resumen

LASSO B, Martín et al. Kaposi sarcoma in HIV patients: Response to antiretroviral treatment and chemotherapy. Rev. méd. Chile [online]. 2003, vol.131, n.5, pp.483-490. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872003000500002.

Background: Kaposi sarcoma is the most common tumor in HIV infected patients. Aim: To describe a cohort of patients with Kaposi sarcoma. Material and methods: Retrospective review of HIV patients with Kaposi sarcoma seen at a public hospital and at a HIV clinic. Detailed description of patients subjected to antiretroviral treatment and chemotherapy. Results: Between 1995 and 2002, 1127 HIV infected patients were seen. Of these, 78 had Kaposi sarcoma, 15 were treated with high activity antiretroviral therapy (HAART) and 17 with HAART and chemotherapy. These 32 patients were male, and their mean age was 33±6 years. The initial CD4 count in 27 of these was 95±105 cells/ml. The initial viral load in 18 of these was 370,246±768,693 RNA copies/ml. Of the 15 patients treated with HAART, eight had a complete remission, one had a partial response, one remained stationary and five died. Of the 17 patients treated with HAART and chemotherapy, seven had complete remission, five had a partial response, 2 remained stationary and three died. The lapse of complete remission was 272 days for those treated with HAART and 292 days for those treated with HAART and chemotherapy. Conclusions: In HIV patients with Kaposi sarcoma, high activity antiretroviral therapy, associated or not to chemotherapy, induces complete remission in 46% of patients and partial remission in 16% (Rev Méd Chile 2003; 131: 483-90).

Palabras clave : Drug therapy; Drug therapy, combination; HIV infections; Sarcoma, Kaposi.

        · texto en Español

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons